Icon ArrowBack
Bio Usawa CEO Menghis Bairu, MD Invited to Prestigious World Local Production Forum and to Preview Africa CDC-IAVI Monoclonal Antibody Manufacturing Capacity Survey Results in Conference Pre-meeting

March 31, 2025 Kigali, Rwanda and San Francisco, USA

Bio Usawa’s Co-Founder, CEO and President, Dr. Menghis Bairu, has been invited to the prestigious World Local Production Forum, to be held in Abu Dhabi, UAE from 7-9 April 2025. Dr. Bairu will join International leaders at various round table and private discussions under the theme “Advancing Local Production for Health Equity, Global Health Security, and Sustainable Development”.

Dr. Bairu will also join select respondents to Africa CDC-IAVI’s survey of the Continent’s monoclonal antibody (mAb) manufacturing capacity at a special invitation-only sideline meeting ahead of the main conference.

The opportunity to engage with leaders in the field of mAb manufacturing is an important pillar in Bio Usawa’s mission to produce high-quality, affordable antibody based therapies in Africa, by Africans, for Africa and beyond.

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.